“Neurofix” obtains a Neotec project that will benefit USAL research groups

Neurofix currently has two products for the treatment of neuropathic pain and for the treatment of paralysis in patients with spinal cord injury.

The Neurofix company, located in the Science Park of the University of Salamanca, has received the support of the CDTI in the NEOTEC call for the execution of the project “Development of therapies for the treatment of paralysis and neuropathic pain in patients with spinal cord injury and other pathologies” , according to the information published by La Gaceta of Salamanca.

Read the full report at this link.

Leave a Reply